Compound Report Overview
Compound Name:
NITRENDIPINE
Compound Identifier:
706520
Mol Structure 2D:
706520
Molecular Weight:
360
Formula:
C18 H20 N2 O6
Development Status:
Launched outside US, not listed by FDA
SMILES:
CCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC)C
Compound Activites
| Compound | Assay | Assay Name | View |
|---|---|---|---|
| NITRENDIPINE | 105 | Cannabinoid CB1 | View |
| NITRENDIPINE | 638 | Testosterone | View |
| NITRENDIPINE | 103 | Calcium Channel Type L, Phenylalkylamine | View |
| NITRENDIPINE | 640 | CYP450-1A2 Inhibition | View |
| NITRENDIPINE | 79 | Adenosine Transporter | View |
| NITRENDIPINE | 42 | Phosphodiesterase PDE4 | View |
| NITRENDIPINE | 121 | Dopamine Transporter | View |
| NITRENDIPINE | 619 | Adenosine A3 | View |
| NITRENDIPINE | 41 | Phosphodiesterase PDE3 | View |
| NITRENDIPINE | 76 | Adenosine A2A | View |
| NITRENDIPINE | 216 | Sodium Channel, Site 2 | View |
| NITRENDIPINE | 641 | CYP450-2C19 Inhibition | View |
| NITRENDIPINE | 642 | CYP450-2C9 Inhibition | View |
| NITRENDIPINE | 620 | Calcium Channel Type L, Benzothiazepine | View |
| NITRENDIPINE | 210 | Serotonin 5-HT6 | View |
| NITRENDIPINE | 89 | Adrenergic beta2 | View |
| NITRENDIPINE | 148 | Histamine H2 | View |
| NITRENDIPINE | 102 | Calcium Channel Type L, Dihydropyridine | View |
| NITRENDIPINE | 92 | Adrenergic, Norepinephrine Transporter | View |
| NITRENDIPINE | 33 | Monoamine Oxidase MAOA | View |
| NITRENDIPINE | 631 | Protein Serine/Threonine Kinase, ERK2 | View |
| NITRENDIPINE | 29 | Leukotriene C4 Synthetase | View |
| NITRENDIPINE | 137 | Glucocorticoid | View |